Medical Imaging AI
ScreenPoint Medical Vendor Risk Profile
ScreenPoint Medical provides Transpara, an AI-powered decision support and detection software for 2D and 3D mammography (Digital Breast Tomosynthesis). It identifies suspicious soft-tissue and calcification lesions and provides a cancer suspiciousness score to assist radiologists in screening and diagnosis.
Risk Score
/100
AI Trust
/100
Compliance Overview
HIPAA Compatible
Yes
BAA Available
Yes
Hosting Model
—
Healthcare Focused
Yes
Approval Status
Approved
Risk Level
Moderate Risk
Last Reviewed
2026-08-18
Last Verified
Verification pending
Review Frequency
Quarterly
Verification reflects VNDRIQ's latest automated source check. Editorial review is a separate human assessment.
AI & Data Policies
AI Training Policy
The algorithm is updated based on additional training and insights gathered from clinical users and de-identified imaging data.
Data Retention Policy
Governed by clinical service agreements and Business Associate Agreements (BAA).
Support Access Risk
—
Approved Use Cases
Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).
Restricted Use Cases
Must be used as a concurrent or second reader by qualified radiologists; not intended for autonomous diagnostic action.
Deployment & Data Residency
Deployment Type
Cloud / On-Premise
Model Type
—
Deployment Environment
—
Hosting Regions
—
Available Regions
—
Data Residency
—
Customer Data Residency Options
—
Cross-Border Data Transfer
—
Data Residency Controls
—
Security & Compliance
SOC 2
Review Required
ISO 27001
Review Required
ISO 42001
—
HIPAA Documentation
—
Encryption
AES-256
SSO
Supported
MFA
Supported
Private Networking
—
Private Endpoints
—
Subprocessors
—
Incident Notifications
—
Security Whitepaper
—
Executive Summary
Primary Use Cases
Key Procurement Considerations
Vendor Trust Score
Limited Trust Data
8
/100
Informational framework based on publicly available and registry data. Not a certification or guarantee. Asterisks indicate categories with limited registry data.
Security & Compliance Dashboard
Standardized view of available registry security information. Not Verified indicates the registry has no documented data.
AI Governance Maturity
Minimal governance documentation; early-stage controls.
Assessed Indicators
Procurement Risk Considerations
Informational considerations for procurement evaluation, not definitive ratings.
Governance Maturity
Foundational
Security Readiness
0/100 security controls
Compliance Readiness
0/100 compliance documentation
Integration Complexity
API not verified — verify integration path
Operational Complexity
Not Verified
Vendor Transparency
0/100 transparency
Healthcare Experience
Healthcare focus not verified
Documentation Completeness
0/100 governance docs
Vendor Lifecycle & Change History
Available registry milestones. Detailed change tracking expands as the registry matures.
Profile Updated
2026-08-26
Last Registry Review
2026-08-18
Registry Added
2026-08-18
Regulated Use Assessment
Healthcare
Healthcare Focused
Yes
HIPAA Compatibility
Yes
BAA Availability
Yes
Financial Services
SOC 2
Review Required
ISO 27001
Review Required
VNDRIQ does not classify vendors as HIPAA Compliant, SEC Compliant, or FINRA Approved unless official evidence exists. Vendor suitability depends on each organization's governance requirements, contractual obligations, deployment model, risk tolerance, and applicable regulations.
Review Notes
Transpara is the first AI application for breast cancer detection in screening mammograms to receive FDA clearance (2018). It is validated by multiple peer-reviewed studies and a randomized controlled trial.
Other Medical Imaging AI Vendors
Quick Facts
Category
Medical Imaging AI
Headquarters
Nijmegen, The Netherlands
Year Founded
2014
Deployment Type
Cloud / On-Premise
Website
Risk Score
/100
AI Trust Score
/100
Last Reviewed
2026-08-18
Last Verified
Verification pending
Request Vendor Evaluation
Get a structured risk assessment and governance recommendation for ScreenPoint Medical.
Vendor Governance
Approval Tier
ApprovedBAA Verification
Not StartedPHI Exposure
HighAI Risk Level
MediumLast Review
2026-08-18
Next Review Due
2026-11-18
Verification Status
Pending Review
Next Review Date
2026-11-18
Review Frequency
Quarterly
Vendor Completeness Score
100/100
CompleteWebsite Present
Category Assigned
Approval Status Present
BAA Status Present
PHI Exposure Classified
Risk Level Present
Review Date Present
Verification Notes Present
Trust & Transparency
Last Reviewed Date
2026-08-18
Review Frequency
Quarterly
Vendor Verification Process
Every vendor is reviewed against public documentation, trust centers, and contract evidence before classification.
Editorial Independence Statement
VNDRIQ classifications are independent of vendor relationships. Ratings reflect available evidence and governance risk only.
Registry Update Policy
The registry is reviewed on a monthly cycle. All updates are editor-reviewed before publication; no automated public data changes.
Editorial Methodology
Vendors are evaluated across compliance, security, AI governance, and enterprise readiness. Each review follows a standardized 12-point checklist covering website, HIPAA, BAA, security, compliance, AI capabilities, deployment, pricing, product changes, ownership, integrations, and documentation.
Trust Signals
Vendor Benchmarking
Comparison against registry averages where supported. Benchmarks are informational and based on registry data.
Related Authority Network
Same Category
Ask VNDRIQ About This Vendor
Ask questions about ScreenPoint Medical using registry data.
Ask VNDRIQ About Healthcare AI Vendors
Explore healthcare AI vendors, compare capabilities, identify documentation gaps, and understand procurement and governance considerations using information from the VNDRIQ registry.
VNDRIQ provides vendor intelligence and educational procurement support. Responses do not constitute legal, medical, cybersecurity, compliance, or procurement advice. Vendor information may be incomplete, vendor-reported, under review, or subject to change.
Do not enter patient information, PHI, passwords, or sensitive data.
VNDRIQ vendor ratings are for operational risk screening and governance support. Final approval should include legal, compliance, security, and contract review before any PHI or regulated data is shared. Risk classifications are based on available public information and internal review at time of last verification.